Related Experiment Video
Updated: Nov 2, 2025

07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
3.8K
Lamotrigine for acute bipolar depression: An exploratory item-level analysis
Evyn M Peters1, Rohit J Lodhi2, Yanbo Zhang3
1Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Brain and Behavior
|June 14, 2021
Summary
Lamotrigine shows promise for bipolar depression by improving core symptoms like sadness and fatigue. This analysis suggests focusing on specific symptoms, not just total scores, may better reveal treatment effects.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Lamotrigine is prescribed for bipolar depression, but evidence for its efficacy is inconsistent.
- Previous studies often rely on total depression scale scores, potentially masking specific treatment effects.
Purpose of the Study:
- To conduct an exploratory item-level analysis of pooled data from placebo-controlled trials of lamotrigine for bipolar depression.
- To identify specific depressive symptoms that are more responsive to lamotrigine treatment.
Main Methods:
- Pooled data from 1072 adult outpatients across five randomized placebo-controlled trials.
- Depressive symptoms assessed using the Hamilton Depression Rating Scale and Montgomery-Åsberg Depression Rating Scale.
- Comparison of change scores on individual scale items between lamotrigine and placebo groups.
Main Results:
- Statistically significant treatment effects observed for items related to depressed mood, anhedonia, pessimism/guilt, and fatigue on both scales.
- Items with higher baseline scores demonstrated larger and statistically significant treatment effects.
- A potential floor effect limited the sensitivity of certain scale items.
Conclusions:
- The findings suggest lamotrigine has a significant treatment effect on core depressive symptoms in bipolar depression.
- Item-level analysis indicates that focusing on specific symptom clusters may be more sensitive than total scale scores for detecting lamotrigine's efficacy.
- Further research is needed to confirm these findings, but they align with existing literature.
Related Concept Videos
Mania and Antimanic Drugs: Overview
396
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
396
Bipolar Disorder
215
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
215
Antidepressant Drugs: MAOIs and Other Agents
523
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
523
Electroconvulsive Therapy
326
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
326

